Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias.

MLA

Baiardi, Simone, et al. “Antemortem CSF Aβ42/Aβ40 Ratio Predicts Alzheimer’s Disease Pathology Better than Aβ42 in Rapidly Progressive Dementias.” Annals of Clinical & Translational Neurology, vol. 6, no. 2, Feb. 2019, pp. 263–73. EBSCOhost, https://doi.org/10.1002/acn3.697.

APA

Baiardi, S., Abu, R. S., Rossi, M., Zenesini, C., Bartoletti, S. A., Polischi, B., Capellari, S., & Parchi, P. (2019). Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer’s disease pathology better than Aβ42 in rapidly progressive dementias. Annals of Clinical & Translational Neurology, 6(2), 263–273. https://doi.org/10.1002/acn3.697

Chicago

Baiardi, Simone, Rumeileh, Samir Abu, Marcello Rossi, Corrado Zenesini, Stella, Anna Bartoletti, Barbara Polischi, Sabina Capellari, and Piero Parchi. 2019. “Antemortem CSF Aβ42/Aβ40 Ratio Predicts Alzheimer’s Disease Pathology Better than Aβ42 in Rapidly Progressive Dementias.” Annals of Clinical & Translational Neurology 6 (2): 263–73. doi:10.1002/acn3.697.